Residents in the capital city buy up at-home tests and fever medication following the government’s decision to ease its “zero Covid” policy.
Tag: Coronavirus (2019-nCoV)
Key Partner in Covax Will End Support for Middle-Income Nations
Many of the poorest countries will continue to get free Covid shots, but global demand for them has plummeted, driving a shift away from the goal of broad coverage.
The Covid Pandemic’s Hidden Casualties: Pregnant Women
Many expectant women have avoided vaccination, unaware that the virus poses great risks to both fetus and mother.
Fringe Group Suspected in German Plot Got a Lift From QAnon
The Reichsbürger movement accused of plotting to overthrow Germany’s government picked up momentum from conspiracy theories that grew during the pandemic.
‘Zero Covid,’ Once Ubiquitous, Vanishes in China’s Messy Pivot
As China casts aside many Covid rules, it is also playing down the threat of the virus. The move could help ease the burden on hospitals but comes with its own risks.
How Will China Turn Its Economy Back On? The World Is About to Find Out.
Strict “zero Covid” curbs have been smothering growth. After easing them, Beijing faces the twin challenges of rising caseloads and wary consumers.
China’s ‘Zero Covid’ Policy, in Pictures
Public unrest erupted across the country after years of disruptive restrictions. These photographs give a glimpse of life under those measures.
China’s ‘Zero Covid’ Policy Changes, Explained
The Chinese government ordered officials to cut back on mass testing and hair-trigger regional lockdowns, in a pivot from stringent pandemic rules.
China Eases ‘Zero Covid’ Restrictions in Victory for Protesters
Beijing’s costly policy of lockdowns has pummeled the world’s second-largest economy and set off mass public protests that were a rare challenge to China’s leader, Xi Jinping.
Global Partners May End Broad Covid Vaccination Effort in Developing Countries
The board of Gavi, the international vaccine agency, meets Wednesday to debate shutting down the program, known as Covax, amid swiftly waning demand for the shots.